Replies to post #81896 on Protagenic Therapeutics Inc. (PTIX)

[Slyder75]

Some quick DD...

One of the most popular ways to value a company in a hyper growth sector, and in turn around mode, is the revenue multiple.

ATRN Competitor

http://finance.yahoo.com/q/ks?s=VCLK+Key+Statistics

Valuation Methods

http://www.accountingtools.com/acquisition-valuation-methods

Given that ATRN is in a hyper growth sector, I think, after reading, that ATRN fair valuation is a multiple of revenues.

Given their direct competitor's multiple, 2-3x revenues seems legit.

That puts valuation anywhere between $1.14-1.72

Hope I'm right...

[overtheedge]

The possibility l am thinking about is .001